Article
LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies.
Journal of cellular and molecular medicine - 1 Jan 2020
Hashemi Mohammad, Sarabandi Sahel, Karami Shima, Śmieja Jarosław, Moazeni-Roodi Abdolkarim, Ghavami Saeid, Łos Marek J
Abstract excerpt
Neuroblastoma (NB), a neuroendocrine tumour, is one of the most prevalent cancers in children. The link between LMO1 polymorphisms and NB has been investigated by several groups, rendering inconclusive results. Here, with this comprehensive systematic review and up-to-date meta-analysis, we aim to distinctively elucidate the possible correlation between LMO1 polymorphisms and NB susceptibility. Eligible studies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
